Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by MirrorWorldManon Jul 14, 2016 8:42am
213 Views
Post# 25051437

RE:RE:RE:Brexit thoughts

RE:RE:RE:Brexit thoughtsI understand what you are saying, that's true for in line products.  The launch Mode of new molecules however takes a little higher expenses. The first 6-9 months are usually critical with drugs and more promotion and commercializations costs etc is required. Once the top line revenue from those drugs are achieved the momentum will carry forward. 
<< Previous
Bullboard Posts
Next >>